Shuimu BioSciences

Shuimu Biosciences' Path to Discovery

In the fast-paced realm of biotechnological innovation, Shuimu Biosciences stands out as a pioneering force, revolutionizing the field of structural biology imaging. Established in 2017 at Tsinghua University, Shuimu Biosciences has rapidly evolved into a leading platform integrating artificial intelligence with cutting-edge cryoimaging technologies.

Unveiling the Invisible: Single-Particle Analysis and High-Resolution Microscopy

At the heart of Shuimu Biosciences' success lies its expertise in single-particle analysis and high-resolution microscopy. These sophisticated techniques allow scientists to visualize and understand the intricate structures of biological macromolecules with unprecedented clarity. By harnessing the power of cryo-electron microscopy (cryo-EM), Shuimu Biosciences provides researchers with detailed images of molecular structures, paving the way for groundbreaking discoveries in drug development and disease understanding.


The Role of Cryo-EM and CryoET

Cryo-EM has become a cornerstone in the study of molecular structures, enabling the visualization of proteins and other macromolecules in their native state. Shuimu Biosciences' state-of-the-art cryo-EM facilities offer high-resolution imaging capabilities that are essential for structural biology research. Additionally, the company is at the forefront of developing and utilizing CryoET (cryo-electron tomography), a technique that allows for the three-dimensional reconstruction of cellular structures. This advanced imaging technology provides deeper insights into the spatial organization of complex biological systems, offering a more comprehensive understanding of cellular functions.

Breakthroughs in Biological Electron Microscopy

Shuimu Biosciences is not only advancing the field through its technological capabilities but also through its contributions to biological electron microscopy. By offering integrated solutions that combine sample preparation, data collection, and analysis, the company ensures that researchers can achieve high-quality results efficiently. This holistic approach to electron microscopy accelerates the pace of discovery and innovation, making it possible to tackle some of the most challenging questions in biology and medicine.


Promoting Innovation and Collaboration

Shuimu Biosciences' commitment to excellence is reflected in its collaborations with over 400 innovative pharmaceutical companies and top-tier research institutions worldwide. By providing access to its cutting-edge technologies and expertise, Shuimu Biosciences fosters an environment of collaboration and innovation. This network of partnerships drives forward the boundaries of what is possible in structural biology and drug discovery.

Visit Shuimu Biosciences

For those interested in exploring the potential of structural biology imaging and high-resolution microscopy, Shuimu Biosciences offers a wealth of resources and opportunities for collaboration. Visit their website to learn more about their groundbreaking work and how they are shaping the future of molecular microscopy and biotechnological research.


Shuimu Biosciences is dedicated to pushing the boundaries of scientific discovery. Their advanced imaging technologies and collaborative approach are paving the way for new treatments and a deeper understanding of the molecular mechanisms that underlie health and disease.


Contact us

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2026 Shuimu Biosciences Ltd.
京ICP备2020035593号